'Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.'

Autor: Rini de Crom, Chris Raske, Alex Maas, Robert F. Berman, Ingeborg Nieuwenhuizen-Bakker, Renate K. Hukema, Lies Anne Severijnen, Michelle Minneboo, Rob Willemsen, Johan M. Kros, Paul J. Hagerman, Ronald A.M. Buijsen
Přispěvatelé: Clinical Genetics, Molecular Genetics, Cell biology, Pathology
Rok vydání: 2014
Předmět:
Apoptosis
enhanced green fluorescent protein
Mitochondrion
Neurodegenerative
Transgenic
Repetitive Sequences
Pathogenesis
Mice
eGFP
caspase 3
Tremor
2.1 Biological and endogenous factors
Aetiology
Tet-On
gpx
Anti-Bacterial Agents
Mitochondria
Liver
Doxycycline
Neurological
Fragile X-associated tremor/ataxia syndrome
ataxia syndrome
medicine.symptom
rtTA
Genetically modified mouse
dox
congenital
hereditary
and neonatal diseases and abnormalities

Ataxia
Transgene
Intellectual and Developmental Disabilities (IDD)
inducible mouse model
Biology
Promoter Regions
cytochrome C
Rare Diseases
Genetic
In vivo
Report
medicine
Genetics
Animals
Molecular Biology
Repetitive Sequences
Nucleic Acid

Nucleic Acid
Animal
gpx-1
Neurosciences
RNA
Cell Biology
Molecular biology
reverse tetracycline transactivator
Brain Disorders
Fatty Liver
Orphan Drug
Fragile X-associated tremor
CGG repeat
Tet Responsive Element
gluthation peroxidase
Fragile X Syndrome
Disease Models
FXTAS
TRE
Biochemistry and Cell Biology
Reactive Oxygen Species
RNA gain-of-function
Developmental Biology
Zdroj: Cell Cycle, 13, 2600-2608. Landes Bioscience
Cell cycle (Georgetown, Tex.), vol 13, iss 16
ISSN: 1538-4101
Popis: Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder affecting carriers of premutation forms of the FMR1 gene, resulting in a progressive development of tremor, ataxia and neuropsychological problems. The disease is caused by an expanded CGG repeat in the FMR1 gene, leading to an RNA gain-of-function toxicity mechanism. In order to study the pathogenesis of FXTAS, new inducible transgenic mouse models have been developed that expresses either 11CGGs or 90CGGs at the RNA level under control of a Tet-On promoter. When bred to an hnRNP-rtTA driver line, doxycycline (dox) induced expression of the transgene could be found in almost all tissues. Dox exposure resulted in loss of weight and death within 5 d for the 90CGG RNA expressing mice. Immunohistochemical examination of tissues of these mice revealed steatosis and apoptosis in the liver. Decreased expression of GPX1 and increased expression of cytochrome C is found. These effects were not seen in mice expressing a normal sized 11CGG repeat. In conclusion, we were able to show in vivo that expression of an expanded CGG-repeat rather than overexpression of a normal CGG-repeat causes pathology. In addition, we have shown that expanded CGG RNA expression can cause mitochondrial dysfunction by regulating expression levels of several markers. Although FTXAS patients do not display liver abnormalities, our findings contribute to understanding of the molecular mechanisms underlying toxicity of CGG repeat RNA expression in an animal model. In addition, the dox inducible mouse lines offer new opportunities to study therapeutic interventions for FXTAS.
Databáze: OpenAIRE